Immunization is an important tool to fight diseases caused by viral, bacterial or fungal pathogenes. The invention provides a new approach for the generation of oligomeric vaccines. The underlying principle is the high affinity interaction between S-protein and a modified S-tag of bovine pancreatic RNase A which is applied to hemagglutinin (H5). The technology can be applied to produce high molecular vaccines. They have many advantages compared to recently used vaccines including high immunogenicity, high stability, short production time and lower production costs. The approach could therefore be used for the immunization of livestock.
Further information: PDF
ESA Patentverwertungsagentur Sachsen-Anhalt GmbH
Phone: +49 (0)391/8 10 72 20
Dr. Detlef Förster
As Germany's association of technology- and patenttransfer agencies TechnologieAllianz e.V. is offering businesses access to the entire range of innovative research results of almost all German universities and numerous non-university research institutions. More than 2000 technology offers of 14 branches are beeing made accessable to businesses in order to assure your advance on the market. At www.technologieallianz.de a free, fast and non-bureaucratic access to all further offers of the German research landscape is offered to our members aiming to sucessfully transfer technologies.
Alle Nachrichten aus der Kategorie: Technology Offerings
Intermolecular rocking vibrations open up channels for ultrafast singlet fission
The search for new, more efficient materials to harvest solar energy is a major research focus around the world. Until now, silicon has been the material of choice for solar…